Parsey Merdad
CIK 0001792150
Chief Medical OfficerDirector
Filings
33
Latest Jun 23, 2025
Issuers covered
4
Showing
33 of 33
Page 1
Track record
18 of 18 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 18 | 22% | -1.3% | -1.8% | +10.1% | -10.8% |
| 90 days | 18 | 39% | -6.7% | -6.9% | +12.0% | -22.1% |
| 180 days | 18 | 22% | -12.8% | -13.6% | +11.3% | -37.6% |
| 365 days | 18 | 22% | -28.8% | -36.2% | +18.0% | -62.8% |
Issuers
Companies where Parsey Merdad has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 27 | Dec 11, 2024 |
| ARDX | Ardelyx, Inc. | 2 | Jun 23, 2025 |
| AVBP | Arrivent Biopharma, Inc. | 2 | Jun 20, 2025 |
| SGMT | Sagimet Biosciences Inc. | 2 | Jun 7, 2024 |
All filings
33 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|